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Abstract. We have previously reported that tlvpolone (T-3), 
2,4-dibromo- 7-methoxyt7vpone (T-21 ) , diethyl 2-chloroazulene-
1 ,3- d icarboxylate (A-9 ) , I ,3- d tfluoroazul ene (A-1 1 ) , 
3-morpholin0-1,5-azulenequinone (AQ-8) and 3,7-dibromo-
1,5-azulenequinone (AQ-13) inhibited the nit/'ic oxide (NO) 
production of lipopolysaccharide (LPS)-activated lnouse 
macl'ophage-like RAW264.7 cells, with ol' without the inhibition 
of inducible NO synthase (iNOS) mRNA and protein 
expression. In order to confirln the anti-inflammatory potency, 
possible effects on prostaglandin (PG) E2 production and the 
expression of enrymes involved in the arachidonic acid pathway 
were investigated. Among these six compounds, only A-9 
effectively inhibited the PGE2 plvduction of the LPS-sti,nulated 
RAW264.7 cells. Weste7'n blot analysis demonstrated tha,t A-9 
inhibited phospholipase A2 (PLA2), cyclooxygenase (COX)-2 
and iNOS proteins only by 12, 45 and 429;~0 , respectively. These 
data demonstrate the lack of correlation between the extent of 
inhibition of iNOS protein expression by tropolone ol' azulene 
del'ivatives and that of PGE2, and suggest th,e possible anti-
inflammatory potency of A-9 . 
We have initiated the structure-activity study of tropolone and 
azulene derivatives. Among 107 compounds so far analyzed, 
tropolone (T-3) , 2,4-dibromo7-methoxytropone (T-21) ( 1) , 
diethyl 2- chloroazulene- I ,3- dicarboxylate (A=9) , I ,3 -
difluoroazulene (A- 11) ( 2) , 3-morpholino- I ,5-azulenequinone 
(AQ-8) and 3,7-dibrom0-1,5-azulenequinone (AQ-13) 
(Figure 1) (3) inhibited the nitric oxide (NO) production of 
lipopolysaccharide (LPS)activated mouse macrophage1ike 
RAW264.7 cells (Table I) , with ( I , 3) or without (2) the 
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inhibi ion of inducible NO synthase (iNOS) mRNA and 
protein expression. Howev r, the extent of inhibition of iNOS 
expression differed considerably from compound to compound 
( 1-3) . Electron-sp n resonance (ESR) spectroscopy showed 
that none of these compounds scavenged the NO released 
from I -hydroxy2ox0-3-(N- 3-methyl- 3-aminopropyl)-3-
methyl- 1-triazene (NO generator) in the presence of 2-(4-
carboxyphenyl ) -4 ,4 ,5 ,5 - tetramethylimidazoline- I - oxy I - 3 -
oxide (a spin trap agent) ( 1-3). In order to confirm the anti-
inflammatory potency of these six compounds , whether or not 
they inhibited the pros aglandin (PG) E2 production of LPS-
stimulated RAW264.7 cells was first investigated. In the 
arachidonic acid (AA) cascade, two enzymes are involved in 
the production of PGE2･ PG synthesis begins with the 
liberati n of AA, the prime precursor, from membrane 
phospholipid  by phospholipase A2 (PLA2) ･ Subsequently, 
cyclo xyg nase (COX) catalyzes the rate-limiting reactions 
for PG synthesis comprisin*' the bis-cyclooxygenation of AA 
to form PGG2 and the peroxidative reduction of this 
intermediate to PGH2 (4) ･ The CPLA2ce is activated by 
proinflammatory cytokines or growth factors and catalyzes the 
AA from he cell surfac membrane (5, 6) . It is known that 
COX has two isoforms, COX- I (constitutive isoform) and 
COX-2 (inducible isoform) (7) . Therefore, the possible effects 
on the expression of these enzymes were also investigated. 
M terials and Methods 
Mat /'ials. The following ch micals and reagents were obtained 
from the indicated companies: Dulbecco's modified Eagle's medium 
(DMEM) (Invitrogen Corp, Carlsbad, CA, USA); fetal bovine 
serum (FBS) (Gemini Bio-Products, Woodland, CA, USA), LPS 
from Escherichia, coli (Serotype O1 1 1:B4) (Sigma Chemical Ind., 
St. Louis, MO, USA) and tropolone (T-3) (Tokyo Kasei Kogyo Co., 
Ltd. , Tokyo , Japan) . 
Synthesis of t,'opolone, azulene and azulenequinone derivatives. 
T-21 (8). , A-9 (9), A-11 (9). AQ-8 (10, 1 1) and AQ-13 (lO, 12, 
13) were prepared, according to the reports in the references cited. 
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Figure I . Structure of compounds used in this study. 
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Cell culture. The RAW264.7 cells, established from the peritoneal 
fluid of BALB/C mice and showing the phenotypic characteristics 
of monocytes and macrophages ( 14) , were subcultured in DMEM 
supplemented with 109~:o heat-inactivated FBS under a humidified 
5 % C02 atmosphere and incubated with various concentrations of 
test compounds in the presence or absence of LPS ( 100 ng/ml) . 
Assayfor cytotoxic activity. The cytotoxic activity of the azulenes was 
determined by the MTT method, and expressed as absorbance at 
540 nm of the MTT- stained cells . The 50% cytotoxic concentration 
(CC50) was determined from the dose-response curve ( 1-3) . 
Assay for NO concentration. Near confluent RAW264.7 cells were 
incubated for 24 hours with each test sample in phenol red-free 
DMEM supplemented with 10% FBS, and the NO production was 
quantified by Greiss reagent, using the standard curve of N02-･ To 
eliminate the interaction between the sample and the Greiss reagent, 
the NO concentration in the culture medium without cells was also 
measured, and subtracted from the value obtained with the cells. 
The condentration that inhibited the LPS-stimulated NO production 
by 50% (50% inhibitory concentration: IC50) was deternrined from 
the dose-response curve ( 1-3). The efficacy of inhibition of NO 
production was evaluated by the selectivity index ( SI) , which was 
calculated by the following equation: SI=CC50 / IC50-
Measurement of PGE2 production. RAW264.7 cells were subcultured in 
24-well plates and incubated with various concentrations of test 
compounds in the presence of LPS ( 100 ng/ml) . The culture supematant 
was collected by centrifugation and the PGE2 concentration was 
detennined by EIA kit (Cayman Chemicai Co, Ann Arbor, MI, USA) . 
Table I. Inhibition of NO production by LPS-stimulated RAW264.7 cells 
by tropolone, azulene and azulenequinone derivatives. 
Cytotoxic I hibition of 
activity NO production 
CC50 (~M) IC50 (uM) 
Compound MW LPS(+) LPS(-) LPS(+) Ref SI 
T-3 
T-21 
A- 9 
A- 1 1 
AQ-8 
AQ- 1 3 
1 22 
294 
307 
1 64 
24 3 
316 
353 
88 
>26 1 
368 
381 
179 
1 45 
102 
>261 
353 
315 
1 65 
12 
<1 
17 
12 
12 ?
31 
>81 
>15 
30 
26 
22 
?
?
?
?
?
Each value represents the mean from three independent experiments. 
CC50: 50~~:(, cytotoxic concentration; IC50: 50% inhibitory 
concentration; SI: selectivity index. 
Western blotting. The cell pellets were lysed with 100 u1 of lysis 
buffer (10 mM Tris-HCI [pH 7.6], I~;~o TritonR X-100, 150 mM 
NaC1 , 5 mM EDTA-2Na and 2 mM phenylmethylsulfonyl fluoride 
(PMSF) for 10 minutes in ice water, and then incubated for 50 
minute at 4'C with RT-5 ROTATOR (Titec, Saitama, Japan) . The 
cell lysates were centrifuged at 16,000 xg for 20 minutes at 4'C to 
remov  the ins luble materials and the supernatant was collected. 
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Figure 2. Effect of six selected colnpounds on PGE2 p"ocluction by LPS-activated RAW264.7 cells. RAW264.7 cells were incubated for 24 hours 
without (control), or with the indicated concentrations of tl'opolone (T-3), 2,4-dibrolno-7-methoxytropone (T-21), diethyl 2-chloroa~zulene-1,3-
dica"boxylate (A-9) , I ,3-dlfluoroazulene (A-11 ) , 3-ln,orpholin0-1,5-azulenequinone (AQ-8), or 3,7-dibromo-1 ,5-a.zulenequinone (AQ-13) , and the 
extracellula" concentration of PGE2 was then measured. 
The protein concentrations of the supernatant were measured by 
Protein Assay Kit (Bio Rad, Hercules, CA, USA) . An equal amount 
of the protein from the cell lysates ( 10 ug) was mixed with 2x 
sodium dodecyl sulfate (SDS)-sample buffer (0.1 M Tris-HCI [pH 
6.8], 20% glycerol, 4% SDS, 0.01% bromphenol blue, 1.2% 2-
mercaptoethanol), boiled for 10 minutes, applied to SDS-8% 
polyacrylamide gel electrophoresis and then transferred to 
polyvinylidene difluoride (PVDF) membrane. The membranes were 
blocked with 5~lfv skim milk in phosphate-buffered saline (PBS(-)) 
plus 0.050/0 Tween 20 for 90 minutes and incubated for 90 minutes 
at room temperature with anti-PLA2, anti-COX-2 or anti-iNOS 
antibody ( I :1 ,OOO; Santa Cruz Biotechnology, Delaware, CA, USA) 
or anti-actin antibody ( I :2,000-4,000; Sigma) and then incubated 
with horseradish peroxidase-conjugated anti-mouse or goat lgG for 
90 minutes at room temperature. The immunoblots were developed 
with a Western Li**htning"T~f Chemiluminescence Reagent Plus 
(Perkin Elmer Life Sciences, Boston, MA, USA) and analyzed on a 
Macintosh (Power Macintosh 7600/120) computer using the public 
domain NlH Image program (National Technical Information 
Service, Springfield, Virginia, USA, part number PB95-500 1 95GEI) . 
Results 
Among the six test compounds, only A-9 inhibited the PGE2 
production of the LPS-stimulated RAW264.7 cells (Figure 
2) . A-9 inhibited the PGE2 production dose-dependently. A= 
9 at 2 or 20 uM inhibited the PGE2 production by 53.2 and 
96.5% , respectively (Figure 3). Western blot analysis 
(Figure 4) demonstrated that A-9 inhibited PLA2, COX-2 
and iNOS proteins by only 12, 45 and 42% , respectively. 
Discussion 
The present study demonstrated that although tropolone (T-3) , 
2,4-dibromo-7-methoxytropone (T-21) , I ,3-difluoroazulene 
(A-11), 3-morpholin0-1 ,5-azulenequinone (AQ-8) and 3,7-
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Figure 3. Dose response ofA-9 in the ilthibition of PGE2 production by 
LPS-stimul ted RAW264.7 cells. RAW264.7 cells were incubated for 24 
hours without (control), or with the indicated concentrations of diethyl 
2-chloroazu[ene-1,3-dica/'boxylate (A-9), and the extracellula/' 
concentration of PGE2 was then inea.su,'ed. Each value represents the 
lnean an,d SD froln three independent experi,11,ents. 
dibromo- I ,5- azulenequinone ( AQ- 13) inhibited NO 
production by LPS-stimulated mouse macrophage=1ike cells, 
these failed to inhibit the PGE2 production of the same cells. 
This suggested tha  the inhibition of NO production by 
macrophages is not an app opriate parameter for evaluating 
anti-inflammatory activity. On the other hand, diethyl 2 
chloroaz lene-1,3-dicarboxylate (A-9) inhibited PGE2 
production (IC50<2 uM) more effilciently than NO production 
(IC50= 17 uM) . These data suggested the importance of fuuher 
investigating A-9 for its possible anti-inflammatory potential. 
It was unexpected that A=9 inhibited COX-2 protein 
expression only by 45% . It also inhibited the iNOS protein 
expression only partially and only marginally affected the 
PLA2 protein expression. The binding assay with 
fluorescence1abe ed LPS d monstrated that A-9 did not affect 
th  b ding of LPS to the cell surface receptor of the 
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Figure 4. Effect of diethyl 2-chloroazulene-1,3-dicarboxylate (A-9) on the intracellular concentration of PLA2' iNOS and COX-2. RAW264.7 cells 
were incubatedfor 24 hours with the indicated concentrations of (A-9) in the absence (-) or presence (+) of 0.1 /lg/ml LPS, and PLA2 (A), COX-
2 (B) or iNOS (C) protein levels were determined by western blot analysis. Each value represents mean and SDfrom three independent experiments. 
RAW'_64.7 cells (Nishishiro, unpublished data) , eliminating 
the possibility that the inhibitory effect of A-9 was due to the 
inhibition of LPS binding to its receptor. It has been reported 
that PLA2(X (15) and COX-2 (16) were activated by 
S-nitrosylation caused by iNOS. Therefore, it remains to be 
investigated whether A=9 inhibits the nitrosylation of PLA2(X 
and COX-2 proteins leading to the lower production of PGE2 -
We have previously reported that a lower concentration 
(16.3 uM) of A-9 slightly reduced the viable cell number 
of RAW264.7 cells w th or without LPS stimulation (as 
shown by the dose-r sp nse curve in Figure 2) (2) . This 
slight reduction of viability might overestimate the extent of 
the inhibition of NO production. However, such a minor 
growth inhibitory effect of A-9 at higher concentrations 
does o  affec  the inhibition of PGE2 production observed 
at much lower c centration. Further study is required to 
elucidate the mechanism of the possible anti-inflammatory 
potency of A-9. 
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